Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Insulin-like growth factor-binding protein-3 (IGFBP-3) interacts with the type II nuclear receptors retinoid X receptor (RXR)α and retinoic acid receptor-α and modulates their transcriptional activity. Peroxisome proliferator-activated receptor (PPAR)γ, a related nuclear receptor that dimerizes with RXRα, plays an important role in adipocyte differentiation. IGFBP-3 is regulated during adipocyte differentiation, but its role in this process is unknown. We demonstrate that IGFBP-3 interferes with the PPARγ-dependent processes of adipocyte differentiation and maintenance of the gene expression characteristic of mature adipocytes. Treatment of adipocytes with exogenous IGFBP-3, but not an IGFBP-3 mutant that does not bind RXRα or PPARγ, decreased markers of adipocyte differentiation, PPARγ, and resistin but increased the preadipocyte marker plasminogen activator inhibitor-1. Furthermore, expression of human IGFBP-3, but not the IGFBP-3 mutant, by preadipocytes inhibited preadipocyte differentiation as determined by gene markers and lipid accumulation. IGFBP-3 interacted with PPARγ in vitro and in 3T3-L1 adipocyte lysates and inhibited PPARγ heterodimerization with RXRα in vitro. Wild-type IGFBP-3, but not mutant IGFBP-3, blocked ligand-induced transactivation of PPAR response element in 3T3-L1 cells. The observation that IGFBP-3 inhibits adipocyte differentiation and impacts on the PPARγ system suggests a role for IGFBP-3 in the pathogenesis of obesity and insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808 · cited 2×
“A possible explanation is that the majority of cellular PPAR is associated with other proteins, such as coactivators or corepressors, that may limit the accessibility of precipitating antibodies (8).”
BackgroundThe nuclear receptor superfamily: a personal retrospect on the first two decades
Chambon, P. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0125 · Cited by 194
Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes
Chan, S. S. Y., Twigg, S. M., Firth, S. M., & Baxter, R. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0595 · Cited by 84 · cited 5×
“Analysis of immunoblots was as described (7).”
BackgroundMethodInfluentialSelf-citationTransferrin Is an Insulin-Like Growth Factor-Binding Protein-3 Binding Protein
Weinzimer, S. A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1806 · Cited by 55
Cited by
p53: key conductor of all anti-acne therapies
Melnik, B. C. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1297-2 · Cited by 78
“IGF binding protein-3 (IGFBP-3) is a nuclear regulator that binds to retinoid X receptor-α (RXRα) and several of its dimerization partners, including nuclear receptor Nur77 and PPARγ [143, 144].”
InfluentialMolecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation
Bugge, A., & Mandrup, S. (2010) · PPAR Research · doi:10.1155/2010/169506 · Cited by 69
Silvert, M., Quintana-Murci, L., & Rotival, M. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.04.016 · Cited by 58
Estrogen Sulfotransferase Inhibits Adipocyte Differentiation
Wada, T., Ihunnah, C. A., Gao, J., Chai, X., Zeng, S., Philips, B. J., Rubin, J. P., Marra, K. G., & Xie, W. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1089 · Cited by 54
Metadata
- Authors
- Chan, S. S. Y., Schedlich, L. J., Twigg, S. M., & Baxter, R. C.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2009-04
- Volume
- 296
- Issue
- 4
- Pages
- E654-E663
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2101587455
- Cited by
- 102
- References
- 5
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. https://app.cochat.ai/papers/10.1152/ajpendo.90846.2008
- The paper
- Chan, S. S. Y., Schedlich, L. J., Twigg, S. M., & Baxter, R. C. (2009). Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.90846.2008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.